-
26-11-2014, 07:42 PM
#10341
Originally Posted by NewGuy
I thought you WERE snapiti?
The frequency and quality of your posts are strikingly similar
Nah Snapiti doesn't have to work if he doesn't want to other than gathering seafood when he feels like it whereas Moosie will be stuck in a museum dusting down sets of antlers for a few more years to come
-
26-11-2014, 07:45 PM
#10342
To be fair though-Snaps did post about how he was concerned about the ''rhetoric'' and was very wary BEFORE the actual sales announcement,so regardless what anyone thinks of him-he did call it that time(or at least was concerned)
Whether his view this time around (or mine, or any ones)is right, is anyone's guess.
(in terms of class of the announcements today--thats already been summed up pretty well)
-
26-11-2014, 08:02 PM
#10343
Originally Posted by NT001
How is DD going to get a rude shock? And who is going to scrutinise the announcement for spelling, grammar and syntax errors? Who really cares?
What we're interested in is the hard facts of the announcement, but there won't be any consensus about whether "the numbers look ok". Some of us demand big numbers, others will be content with smaller ones and quite a few are really only interested in whether the company is making progress towards its strategic objectives. Traders and investors have very widely varying criteria.
I doubt if DD will be following comments on this thread with great anxiety, if at all. There ought to be an apology to shareholders from him on Friday for today's cockup and then it should be buried, but lessons drawn from it - not grammar and syntax, but how to manage external PR.
Oh dear. Looks like a humour bypass operation has taken place in Wellington!
Last edited by pierre; 26-11-2014 at 08:03 PM.
-
26-11-2014, 08:31 PM
#10344
There will still be some folks out there (not s.t. followers) who are not aware of the correct information regarding the patent. I just checked my ASB Sharetrading account and clicked the box next to PEB in my watch list, and the first announcement comes up re- CX-Blabber! I'm wondering if trades will be reversed due to the stuff-up?
-
26-11-2014, 08:38 PM
#10345
Originally Posted by pierre
Oh dear. Looks like a humour bypass operation has taken place in Wellington!
Not really, but you certainly had me fooled.
-
26-11-2014, 08:52 PM
#10346
Originally Posted by penn
There will still be some folks out there (not s.t. followers) who are not aware of the correct information regarding the patent. I just checked my ASB Sharetrading account and clicked the box next to PEB in my watch list, and the first announcement comes up re- CX-Blabber! I'm wondering if trades will be reversed due to the stuff-up?
You know the ASB guy on the TV3 news spent a full five minutes tonight telling us about the Cxbladder patent too, but when I reflected he was not incorrect, Pacific Edge have indeed told us the patent is coming, it’s just coming in February next year after all. By the time we all recover from xmas and a failed new year’s resolution or two it will be on the shelf next to the Cxcolorectal patent.
Re: second of three announcements today:
https://www.nzx.com/files/attachments/204523.pdf
Correction on Pacific Edge Limited Patent Issue
Pacific Edge Limited ("the Company") advises the market that it has incorrectly posted the NZX release for the issue of its bladder cancer patent in Europe.
The Company’s bladder cancer patent has not issued however the patent has successfully completed examination and the Company has been advised by the European Patent Office that the patent will issue by February 2015.
The Company wishes to inform the market that Pacific Edge’s colorectal cancer biomarker patent has issued in Europe. Details of this are provided in the Company's separate announcement.
End
-
26-11-2014, 09:08 PM
#10347
Yep, good news is good news. Who knows it may be a tad easier to get sales traction in Liechtenstein, Turkey, Monaco, Iceland, Norway, the Republic of Macedonia,
San Marino, Albania and Serbia. Than the good ole' US of A.
-
26-11-2014, 09:27 PM
#10348
Originally Posted by penn
Yep, good news is good news. Who knows it may be a tad easier to get sales traction in Liechtenstein, Turkey, Monaco, Iceland, Norway, the Republic of Macedonia,
San Marino, Albania and Serbia. Than the good ole' US of A.
Seriously though, it may very well do so for many of 38 European countries covered, particularly France, Germany, UK etc.
If they enter in one or two year’s time with a hoard of US generated cash to fund it, a healthy US market share as a representation of confidence, any number of further published studies by that time, and of course probably the full suite of four cxbladder products, it may well just pick up quite quickly.
Certainly there is intent to be read into the announcements, I don't think analysts will start to work up a valuation for a European launch until later next year though, would like to be proven wrong though.
-
26-11-2014, 10:05 PM
#10349
Snapiti is currently putting together a good behaviour bond to get out of jail soon.
(He really just can't remember his password because he's getting so old)
-
27-11-2014, 07:31 AM
#10350
Originally Posted by MAC
You know the ASB guy on the TV3 news spent a full five minutes tonight telling us about the Cxbladder patent too, but when I reflected he was not incorrect, Pacific Edge have indeed told us the patent is coming, it’s just coming in February next year after all. By the time we all recover from xmas and a failed new year’s resolution or two it will be on the shelf next to the Cxcolorectal patent.
Re: second of three announcements today:
https://www.nzx.com/files/attachments/204523.pdf
Correction on Pacific Edge Limited Patent Issue
Pacific Edge Limited ("the Company") advises the market that it has incorrectly posted the NZX release for the issue of its bladder cancer patent in Europe.
The Company’s bladder cancer patent has not issued however the patent has successfully completed examination and the Company has been advised by the European Patent Office that the patent will issue by February 2015.
The Company wishes to inform the market that Pacific Edge’s colorectal cancer biomarker patent has issued in Europe. Details of this are provided in the Company's separate announcement.
End
It bothers me that management are priming the stock with immaterial news (at least in this point in time) days prior to the announcement.
Truth is like poetry. And most people f*cking hate poetry.
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks